Skip to main content
Clinical Trials/NCT06535698
NCT06535698
Completed
Not Applicable

A Single-Group Clinical Trial to Evaluate the Effect of an Oral Supplement to Provide Relief From Symptoms of Hormonal Imbalance.

Perelel Inc.1 site in 1 country35 target enrollmentStarted: February 19, 2024Last updated:
ConditionsWomen's Health

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Perelel Inc.
Enrollment
35
Locations
1
Primary Endpoint
Changes in Symptoms of Hormonal Imbalance

Overview

Brief Summary

This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid new hormonal balance treatments during the study
  • Consistent use of current hormonal balance treatments for at least 3 months prior to the study

Exclusion Criteria

  • Chronic conditions preventing adherence to the protocol Diabetes
  • Planned hormonal balance-related procedures during the study
  • Started any new medications or supplements that target hormonal balance in the past 3 months
  • Anyone with diabetes
  • Severe allergies requiring EpiPen
  • Pregnant, breastfeeding, or trying to conceive
  • Recent surgeries or planned surgeries during the study
  • Unwilling to follow the study protocol

Outcomes

Primary Outcomes

Changes in Symptoms of Hormonal Imbalance

Time Frame: Baseline, Week 4, Week 8, Week 12

Evaluation of the effect of Perelel Health hormonal balance support on symptoms of hormonal imbalance using a self-reported questionnaire.

Secondary Outcomes

  • Changes in Overall Menstrual Health(Baseline, Week 4, Week 8, Week 12)

Investigators

Sponsor
Perelel Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials